Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/21/2025
-
GuruFocus
4/21/2025
-
GuruFocus
4/21/2025
-
The Fly
4/13/2025
-
MarketBeat
4/11/2025
-
GuruFocus
4/11/2025
-
GuruFocus
4/11/2025
-
PR Newswire
4/11/2025
-
Ticker Report
4/10/2025
-
GuruFocus
4/10/2025
-
SeekingAlpha.com: All News
4/10/2025
-
Stocktwits News Feed
4/10/2025
-
GuruFocus
4/9/2025
-
GuruFocus
4/9/2025
-
The Fly
4/9/2025
-
PR Newswire
4/9/2025
-
GuruFocus
4/9/2025
-
GuruFocus
4/9/2025
-
GuruFocus
4/9/2025
-
Seeking Alpha - Healthcare
4/9/2025
-
SeekingAlpha.com: All News
4/9/2025
-
TipRanks Financial Blog
4/9/2025
-
The Fly
4/9/2025
-
PR Newswire
4/3/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
Total Liabilities (Q)
--
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
917 813 1828
Address
360 Madison Avenue
New York, NY 10017
New York, NY 10017
Country
Year Founded
Business Description
Sector
Industry
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who...
more